Results: Access site cross over was needed in 1 patient (0.002%), and conversion from sheathless guiding catheter to conventional guiding catheter in 1 patient (0.002%). Acute procedural success rate was 95. 9%. The median duration of the procedures was 50min . The median time of fluoroscopy was 16.5min ). The median contrast media use was 136ml . Guiding catheter-induced coronary artery dissection occurred in 1 patient. Conclusions: Routine use of the Sheathless guide catheter for TRA in PPCI for STEMI is feasible with a low crossover rate and a high rate of procedural success.
Conclusions: Based on the previous data, transbrachial approach for PCI could be a good alternative for the standard of care approaches with considerable safety and efficacy. Background: Use of bleeding avoidance strategies (BAS) such as transradial access, bivalirudin, and femoral closure devices have been shown to lower bleeding events after PCI but used most often in those at lowest risk of bleeding. Patient characteristics that deter use of BAS in higher risk patients for bleeding are not clearly established. Methods: Patients undergoing PCI at four University of Pittsburgh Medical Center affiliated hospitals were enrolled in a hospital-based registry and followed prospectively beginning in October 2011. Bleeding events and bleeding risk score (BRS) were defined by NCDR criteria and definitions. Low risk of bleeding defined as score<13 and high risk of bleeding as score!13. Results: Among 2178 consecutive PCI patients (66.7% for acute coronary syndrome), 978 patients had a calculated BRS of <13 and 1200 patients !13. BAS use more likely in the low risk group (91.1 vs 83.0%, p¼0.0001). Specific strategy used in the low and high-risk groups were femoral access closure only in 23.5 vs 28.2% (p¼0.01), bivalirudin only in 21.6 vs 21.1% (p¼0.78), transradial access only in 4.1 vs 3.8% (p¼0.68), and a combination of BAS in 41.9 vs 30% (p¼0.0001). Among the high risk group, logistic regression was used to determine the independent risk factors associated with use of BAS (Figure 1 ).
Conclusions: Utilization of a BAS has been increasingly advocated for especially in high-risk patients for bleeding. However, recognizing deterrents to utilization allows for understanding if use is even feasible and further studies are necessary to study the safety and efficacy of BAS in higher risk patients. Background: Despite advances in interventional cardiology, and that safety and feasibility of outpatient percutaneous coronary intervention (PCI) has been previously demonstrated, overnight stay after PCI remains the standard of care in the United States. The study aims to compare outcomes, patient satisfaction, and cost of same day (SD) vs. delayed hospital discharge (DD) after PCI-stenting and femoral hemostasis with a vascular closure device (StarClose or ProGlide). Methods: Consecutive patients undergoing coronary angiography (n¼2,480) at University of Southern California Hospitals were screened; 493 patients were consented for inclusion. Four hours following PCI, 100 patients were randomized to SD (n¼50) or DD (n¼50). Patients were followed for one month and patient satisfaction surveys completed at 24 hours and one-month post discharge. Cost savings were calculated based on Medicare payment rates. Results: SD and DD groups were well distributed with similar baseline demographic and angiographic characteristics. Mean age was 58.1AE8.8, 86% were male, 16% smokers, 44% diabetic, 41% had history of MI and 31% CRI. NSTEMI or unstable angina (UA) was the presentation in 30% of SD vs. 44% of DD patients (p¼0.2) and all other patients had stable angina (SA) (70% in DD vs. 56% in SD, p¼0.15). Multivessel stenting was performed in 74% and 60% of SD and DD groups, respectively (p¼0.14). At 30 days post-discharge, the primary end point (death, myocardial infarction or repeat revascularization) occurred in one DD patient (2%) vs. two SD patients (4%), p¼1.0. The secondary end points of Primary Safety and efficacy Endpoints between TBA,TRA and,TFA.
TBA (1102) TRA (2797) TFA (1054) Background: Although acute myocardial infarction (MI) and cardiogenic shock are known to predict post-percutaneous coronary intervention (PCI) bleeding, the association between post-PCI bleeding and the severity of clinical presentation has not been clearly defined. This study aims to compare the incidence and predictors of post-PCI bleeding across different clinical presentations. Methods: The study included 23943 consecutive PCI patients categorized according to their clinical presentation: stable angina pectoris (SAP, n¼6741), unstable angina pectoris (UAP, n¼5215), non-ST-segment elevation MI (NSTEMI, n¼8418), ST-segment elevation MI (STEMI, n¼2721), and cardiogenic shock (CGS, n¼848).
Results: There was greater use of pre-procedural anticoagulation, intra-aortic balloon pump and glycoprotein receptor inhibitors with increasing severity of clinical presentation. The incidence of Thrombolysis In Myocardial Infarction (TIMI) major and minor bleeding increases with severity of clinical presentation. (Figure 1 ) On multivariate logistic regression analysis, (Figure 2 )NSTEMI, STEMI and CGS remain independently predictive of bleeding after adjusting for baseline and procedural differences, whereas UAP did not. In-hospital mortality corresponded with severity of clinical presentation, from 0.2% in SAP to 24.4% in CGS. Conclusions: In patients undergoing PCI, the worsening severity of clinical presentation corresponds to an increase in incidence of post-PCI bleeding. The increased bleeding risk persisted despite adjusting for more aggressive pharmacotherapy and use of IABP with increasing severity of clinical presentation.
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Safety of diagnostic transradial cardiac catheterization of outpatients under oral anticoagulation with Acenocumarol. Background: Increasingly frequent performing invasive cardiac procedures without removing oral anticoagulation, however the need for withdrawal of oral anticoagulants before transradial cardiac catheterization in patients chronically anticoagulated remains controversial. It is usually removed at least 48-72 hours before the procedure and in selected patients, heparin is used as bridge therapy. We evaluate the efficacy and safety of performing transradial catheterization in outpatients without removal of warfarin. Methods: 268 patients undergoing transradial cardiac catheterization. 40 patients chronically anticoagulated with Acenocumarol(Group A) were compared with the rest (Group B). The hemostasis technique was similar in both groups as a patent hemostasis assessed by plethysmography (elastic compression with a band during 2 hours). We assessed the development of complications after the removal of bandage while patients still were in laboratory and in first 24 hours. Radial patency was assessed by plethysmography and hematomas were classified according EASY classification. Bleeding and other complications were also recorded. Results: Patients in Group A were older (72AE8 vs 65AE11 years old; p¼0,01) without other difference in baseline characteristics. Atrial fibrillation (60%) was the main cause for warfarin and the mean INR at the time of procedure was 2,4AE0,5. During the procedure there wasn't any remarkable complication and there wasn't difference in time for procedure between groups. When the bandage were removed, it was 1,8% of bleeding in Group B who required new compression (0% in Group A (p>0.05)) and only one radial occlusion (Group B). No difference in hematomas 5 cm (7.5% vs 6.6%, p>0.05). In first 24 hours, no early or late hematomas call for additional attendance and there was 1.8% late mild bleeding in Group B vs 0% in Group A. No cases with hematomas >10 cm or extended to the arm, no compartment syndrome and no other complications as fistulas, pseudoaneurysms, dissections or perforations. Conclusions: Performing transradial diagnostic cardiac catheterization without withdrawal of oral chronic anticoagulation is safe, with low rates of thrombotic and hemorragic complications.
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Which patients are still having PCI via the Femoral approach in centres that are default Radial centres? Results and Insights from a single centre experience. 
